Apr 25, 2023 / 03:30PM GMT
James Tran - Bloom Burton & Co. - Moderator
Great. Our next presentation is HLS Therapeutics. Joining us today is Tim Hendrickson, the CFO. After his presentation, there will be five minutes for questions and answers.
Tim, please take it away.
Tim Hendrickson - HLS Therapeutics Inc. - CFO
Fantastic. Thanks, James. And thanks to Brian, Julian, and the fantastic team at Bloom Burton for putting on this great conference every year and for the invitation for us to take part today. And welcome, thank you for joining us today.
Over the next 20, 25 minutes, I'll give you a good general overview of HLS before proceeding to Q&A. As you may know, earlier this month, we announced the transition with Craig Millian stepping into the CEO role as Gilbert Godin is retiring.
Craig's first day will be May 1, coming up very soon. And I know he looks forward to engaging with the Street in the weeks and months to come, and looking forward to that.
So let's move on to today's presentation. Quick overview of who we are. HLS is an
HLS Therapeutics Inc at Bloom Burton & Co Healthcare Investor Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot